"beta Catenin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A multi-functional catenin that participates in CELL ADHESION and nuclear signaling. Beta catenin binds CADHERINS and helps link their cytoplasmic tails to the ACTIN in the CYTOSKELETON via ALPHA CATENIN. It also serves as a transcriptional co-activator and downstream component of WNT PROTEIN-mediated SIGNAL TRANSDUCTION PATHWAYS.
| Descriptor ID |
D051176
|
| MeSH Number(s) |
D12.776.091.249 D12.776.220.145.500 D12.776.930.130
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "beta Catenin".
Below are MeSH descriptors whose meaning is more specific than "beta Catenin".
This graph shows the total number of publications written about "beta Catenin" by people in this website by year, and whether "beta Catenin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 2 | 2 |
| 1995 | 0 | 2 | 2 |
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 2 | 2 |
| 1998 | 0 | 3 | 3 |
| 1999 | 0 | 3 | 3 |
| 2000 | 0 | 8 | 8 |
| 2001 | 0 | 7 | 7 |
| 2002 | 0 | 18 | 18 |
| 2003 | 0 | 20 | 20 |
| 2004 | 0 | 12 | 12 |
| 2005 | 2 | 11 | 13 |
| 2006 | 5 | 3 | 8 |
| 2007 | 11 | 7 | 18 |
| 2008 | 13 | 11 | 24 |
| 2009 | 8 | 12 | 20 |
| 2010 | 8 | 16 | 24 |
| 2011 | 11 | 12 | 23 |
| 2012 | 15 | 10 | 25 |
| 2013 | 12 | 12 | 24 |
| 2014 | 9 | 12 | 21 |
| 2015 | 10 | 11 | 21 |
| 2016 | 9 | 10 | 19 |
| 2017 | 7 | 6 | 13 |
| 2018 | 11 | 4 | 15 |
| 2019 | 7 | 9 | 16 |
| 2020 | 6 | 7 | 13 |
| 2021 | 4 | 3 | 7 |
| 2022 | 1 | 8 | 9 |
| 2023 | 2 | 7 | 9 |
| 2024 | 2 | 3 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "beta Catenin" by people in Profiles.
-
Dissecting the novel molecular interactions of solute carrier family 4 member 4 (SLC4A4) for prostate cancer (PCa) progression. Sci Rep. 2024 11 25; 14(1):29133.
-
Protein kinase D1 mitigation against etoposide induced DNA damage in prostate cancer is associated with increased a-Catenin. Prostate. 2025 Feb; 85(2):156-164.
-
MARK2 variants cause autism spectrum disorder via the downregulation of WNT/?-catenin signaling pathway. Am J Hum Genet. 2024 Nov 07; 111(11):2392-2410.
-
Preliminary study of extracorporeal shock wave alleviating joint capsule fibrosis caused by internal bleeding of knee joint in rats. Connect Tissue Res. 2024 Sep; 65(5):397-406.
-
A Mouse Model for Conditional Expression of Activated ?-Catenin in Epidermal Keratinocytes. Transgenic Res. 2024 Oct; 33(5):513-525.
-
Genetic inactivation of ?-catenin is salubrious, whereas its activation is deleterious in desmoplakin cardiomyopathy. Cardiovasc Res. 2023 12 30; 119(17):2712-2728.
-
TRIOBP modulates ?-catenin signaling by regulation of miR-29b in idiopathic pulmonary fibrosis. Cell Mol Life Sci. 2023 Dec 29; 81(1):13.
-
Muscarinic receptor agonist-induced ?Pix binding to ?-catenin promotes colon neoplasia. Sci Rep. 2023 10 07; 13(1):16920.
-
Proteogenomic insights suggest druggable pathways in endometrial carcinoma. Cancer Cell. 2023 09 11; 41(9):1586-1605.e15.
-
?-aminobutyric acid B2 receptor: A potential therapeutic target for cholangiocarcinoma in patients with diabetes mellitus. World J Gastroenterol. 2023 Jul 28; 29(28):4416-4432.